| Q1  2026 |
| ≡ |
Seth Klarman - Baupost Group |
Buy |
3,630,000 |
1.33 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 8.32% |
441,512 |
0.31 |
| ≡ |
John Rogers - Ariel Investments |
Add 2.16% |
310,212 |
0.06 |
| Q4  2025 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 16.28% |
743,257 |
0.64 |
| ≡ |
John Rogers - Ariel Investments |
Add 18.76% |
2,267,075 |
0.55 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
100,561 |
0.03 |
| Q3  2025 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.05% |
143,708 |
0.14 |
| ≡ |
John Rogers - Ariel Investments |
Reduce 2.30% |
285,085 |
0.08 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
100,561 |
0.03 |
| Q2  2025 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 31.15% |
1,118,486 |
1.02 |
| ≡ |
John Rogers - Ariel Investments |
Add 36.21% |
3,288,207 |
0.75 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
287,337 |
0.10 |
| Q1  2025 |
| ≡ |
John Rogers - Ariel Investments |
Add 126.82% |
5,077,531 |
1.13 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 44.54% |
1,106,284 |
1.08 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 180.96% |
185,067 |
0.06 |
| Q4  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 11.35% |
318,141 |
0.38 |
| ≡ |
John Rogers - Ariel Investments |
Reduce 24.74% |
1,315,769 |
0.36 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 70.08% |
239,525 |
0.12 |
| Q3  2024 |
| ≡ |
John Rogers - Ariel Investments |
Reduce 6.37% |
361,868 |
0.08 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 85.12% |
157,160 |
0.06 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.24% |
35,058 |
0.04 |
| Q2  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 17.56% |
423,748 |
0.42 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
184,635 |
0.07 |
| ≡ |
John Rogers - Ariel Investments |
Reduce 2.89% |
169,141 |
0.03 |
| Q1  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 4.75% |
120,325 |
0.12 |
| Q4  2023 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 0.04% |
1,012 |
0.00 |
| Q3  2023 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 18.20% |
563,997 |
0.55 |
| Q2  2023 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 526.48% |
2,603,994 |
3.16 |
| ≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
3,547,135 |
2.98 |
| Q1  2023 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 6.75% |
256,848 |
0.22 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.69% |
8,500 |
0.05 |
| Q4  2022 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 7.57% |
311,524 |
0.25 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 8.14% |
37,850 |
0.23 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
209,495 |
0.05 |
| Q3  2022 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Add 2.20% |
10,000 |
0.06 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 0.79% |
32,237 |
0.02 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 23.08% |
62,842 |
0.01 |
| Q2  2022 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 12.25% |
570,232 |
0.35 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 7.30% |
35,850 |
0.20 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
272,337 |
0.08 |
| Q1  2022 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.48% |
17,700 |
0.15 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 0.17% |
7,792 |
0.01 |
| Q4  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 29.17% |
1,049,243 |
0.77 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
69,960 |
0.02 |
| Q3  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 9.83% |
392,239 |
0.36 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
69,960 |
0.02 |
| Q2  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 3.05% |
118,161 |
0.09 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
54 |
0.00 |
| Q1  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 48.25% |
1,259,698 |
0.99 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
54 |
0.00 |
| Q4  2020 |
| ≡ |
Bill Miller - Miller Value Partners |
Buy |
2,610,847 |
2.22 |
| Q3  2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
55,023 |
0.02 |
| Q2  2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 2771.76% |
53,107 |
0.02 |
| Q1  2020 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Sell 100.00% |
133,000 |
1.20 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
1,916 |
0.00 |
| Q3  2019 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Add 40.00% |
38,000 |
0.31 |
| Q2  2019 |
| ≡ |
Robert Olstein - Olstein Capital Management |
Buy |
95,000 |
0.83 |
| Q4  2017 |
| ≡ |
Leon Cooperman |
Sell 100.00% |
125,000 |
0.26 |
| Q2  2017 |
| ≡ |
Leon Cooperman |
Buy |
125,000 |
0.28 |